Skip to content

Who Coined the Term Geroscience?

3 min read

The interdisciplinary field of geroscience, which posits that targeting the aging process can prevent multiple chronic diseases, was conceptualized and actively championed by Dr. Felipe Sierra. He is widely recognized for making geroscience an internationally acknowledged research field during his tenure at the National Institute on Aging (NIA).

Quick Summary

The term geroscience was established by Dr. Felipe Sierra to describe the intersection of basic aging biology and chronic disease. It aims to prevent age-related illnesses by addressing the fundamental biological processes of aging itself, a concept he spearheaded at the National Institute on Aging.

Key Points

  • Term Coined by Felipe Sierra: The former director of the National Institute on Aging's (NIA) Division of Aging Biology, Dr. Felipe Sierra, is credited with coining and popularizing the term "geroscience".

  • Rooted in Aging Biology: Geroscience builds upon the science of aging biology, but applies this knowledge toward understanding how aging drives chronic disease.

  • Core Hypothesis: The central principle is that addressing the biological mechanisms of aging can prevent or delay multiple age-related diseases simultaneously, extending healthspan more effectively than treating individual illnesses.

  • Established at NIH: Dr. Sierra was the driving force behind the creation of the Trans-NIH Geroscience Interest Group (GSIG) in 2012, which galvanized interest in the field across different health institutes.

  • Distinct from Gerontology: While gerontology broadly studies aging, geroscience specifically investigates the biological and molecular links between aging and chronic disease.

  • Pillars of Geroscience: The field is built on identified biological mechanisms, or "pillars," including cellular senescence, inflammation, and mitochondrial dysfunction.

In This Article

Dr. Felipe Sierra's Role at the National Institute on Aging (NIA)

Dr. Felipe Sierra, as the former director of the National Institute on Aging's (NIA) Division of Aging Biology, was instrumental in popularizing and formalizing the concept of geroscience. A key idea behind geroscience is that aging is the primary risk factor for many chronic diseases, and focusing on aging biology could be a more effective preventive approach than treating individual diseases.

Under his guidance, the Trans-NIH Geroscience Interest Group (GSIG) was formed in 2012 to encourage interdisciplinary research across different National Institutes of Health branches. The GSIG brought together researchers from various fields to consider aging as an underlying factor in multiple diseases.

The Birth and Development of the Geroscience Concept

The formal concept of geroscience grew from earlier discoveries in aging biology. Sierra and colleagues organized Geroscience Summits to advance the field and define the "Pillars of Geroscience" – the key biological processes driving aging.

Significant developments in geroscience include linking basic aging biology to chronic diseases and proposing simultaneous interventions, the formation of the GSIG in 2012, and a series of Geroscience Summits to formalize the concept and its pillars. The field is now progressing towards human clinical trials of promising compounds.

Comparing Geroscience with Related Fields

The table below compares geroscience with gerontology and geriatrics.

Feature Geroscience Gerontology Geriatrics
Primary Focus The basic biological mechanisms of aging as they relate to chronic disease. The broad, multidisciplinary study of aging in all its aspects (social, psychological, biological). The clinical care and treatment of older adults and their diseases.
Goal To prevent or delay the onset of multiple age-related diseases by targeting the root causes of aging. To understand the aging process in its entirety to better support the well-being of older people. To manage and treat existing health problems in older patients to improve their quality of life.
Approach Interdisciplinary, bringing together basic biologists, clinicians, and researchers focused on specific diseases. Comprehensive, drawing on sociology, psychology, public health, and biology to analyze aging. Clinically focused on diagnosis, treatment, and care plans for older patients with age-related conditions.
Time Horizon Preventive, aiming to extend healthspan before chronic diseases manifest. Broad, studying the entire lifespan and its effects on individuals and society. Reactive, addressing medical issues as they arise in older age.

The Pillars of Geroscience

The Geroscience Summits identified several key biological processes contributing to aging and linked to chronic disease. These pillars include:

  • Genomic Instability: Accumulation of genetic damage.
  • Epigenetic Alterations: Changes in gene expression.
  • Cellular Senescence: Cells stop dividing and release inflammatory signals.
  • Loss of Proteostasis: Declining ability to maintain proper protein function.
  • Mitochondrial Dysfunction: Decline in energy-producing function.
  • Inflammation: Chronic, low-grade inflammation.
  • Stem Cell Exhaustion: Diminishing capacity of stem cells.

Conclusion: The Impact of Geroscience

While earlier researchers studied aging, Dr. Felipe Sierra is credited with coining the term geroscience and defining its focus. His efforts helped establish geroscience as a field focused on the biological causes of age-related decline. Research aims to develop interventions to extend healthspan for a growing population. This focus on the biology of aging shows promise for future health. Further details can be found on the {Link: National Institute on Aging (NIA) Geroscience page https://www.nia.nih.gov/research/dab/geroscience-intersection-basic-aging-biology-chronic-disease-and-health}.

Frequently Asked Questions

While Dr. Felipe Sierra is credited with coining and championing the term, the establishment of the field was a collaborative effort. The National Institutes of Health (NIH) formed the Trans-NIH Geroscience Interest Group (GSIG) involving many researchers, and Gordon Lithgow was also a key figure in forming the Interdisciplinary Research Consortium on Geroscience at the Buck Institute.

The main distinction is focus. Gerontology is the broad, multidisciplinary study of aging, encompassing biological, social, and psychological aspects. Geroscience, conversely, is a more specific, biomedical field that focuses exclusively on the intersection of the basic biology of aging and chronic, age-related diseases.

Geroscience is important because it proposes a powerful new paradigm for medicine. By focusing on the root biological causes of aging, it aims to prevent multiple age-related chronic diseases, such as cancer, diabetes, and heart disease, with a single, targeted intervention.

The geroscience hypothesis posits that since aging is the single greatest risk factor for many chronic diseases, interventions that target the fundamental biological processes of aging can delay or prevent the onset of these diseases simultaneously.

The key pillars of geroscience include genomic instability, cellular senescence, inflammation, mitochondrial dysfunction, and epigenetic alterations. These are the cellular and molecular pathways that researchers believe drive the aging process.

Geroscience research progresses from studying aging mechanisms in model organisms like mice and worms to testing promising compounds, known as geroprotectors, in human clinical trials. Notable examples include trials for rapamycin and metformin.

A successful geroscience intervention doesn't just aim to extend lifespan, but to extend healthspan—the period of life spent free from chronic disease and disability. The ultimate goal is to compress morbidity into a shorter period at the very end of life.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice. Always consult a qualified healthcare provider regarding personal health decisions.